Background This systematic review and meta-analysis investigated the diagnostic performance of F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) or PET/computed tomography (PET/CT) for the detection of disease recurrence after curative resection of gastric cancer.
Methods The PubMed and Embase databases, from the earliest available date of indexing through November 30, 2019, were searched for studies evaluating the diagnostic performance of F-18 FDG PET or PET/CT to detect recurrent disease after gastric cancer surgery.
Results Across 17 studies (1,732 patients), the pooled sensitivity for F-18 FDG PET or PET/CT was 0.82 (95% confidence interval [CI], 0.74–0.88) with heterogeneity of I2=76.5 (p<0.001), and the specificity was 0.86 (95% CI, 0.78–0.91) with heterogeneity of I2=94.2 (p<0.001). Likelihood ratio (LR) tests gave an overall positive LR of 6.0 (95% CI, 3.6–9.7) and negative LR of 0.2 (95% CI, 0.14–0.31). The pooled diagnostic odds ratio was 29 (95% CI, 13–63). The summary receiver operating characteristic curve indicates that the area under the curve was 0.91 (95% CI, 0.88–0.93).
Conclusion The current meta-analysis showed good sensitivity and specificity of F-18 FDG PET or PET/CT for detecting recurrent disease after curative resection of gastric cancer despite heterogeneity in ethnicity, recurrence rate, histology, and interpretation method.
Citations
Citations to this article as recorded by
Personalized PET Imaging in Gastric Cancer: An Umbrella Review of Meta‐Analyses to Guide Radiopharmaceutical Selection and Clinical Indication Aiganym Amrenova, Alma Shukirbekova, Sholpan Akhelova, Jamilya Assilbayeva, Andrey Gurin, Maira Ualieva, Bibigul Kaliyaskarova, Asset Sarsekeyev, Nadiar M. Mussin, Amin Tamadon, Swarbhanu Sarkar International Journal of Biomedical Imaging.2026;[Epub] CrossRef
Follow-Up and Strategies After Curative Surgical Resection for Gastric Cancer Seokin Kang The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2025; 25(4): 336. CrossRef